{"podcast":{"title":"Hematologic Oncology Update","slug":"hematologic-oncology-update-916423","podcast_index_feed_id":916423,"rss_url":"https://feeds.captivate.fm/hematologic-oncology/","website_url":"https://www.researchtopractice.com/browse-tumor-types/hematologic-oncology","image_url":"https://artwork.captivate.fm/385e0bc2-3e77-4650-a103-033cd89470e0/VM1-kJu7V4rmiKPVI6DGtcq3.png","author":"Dr. Neil Love","episode_count":145,"summary":"Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.","last_synced_at":"2026-07-10T00:19:38.916639+00:00","page_url":"https://stenobird.com/podcast/hematologic-oncology-update-916423"},"episode":{"title":"Bispecific Antibodies in the Management of Lymphoma — ASH 2025 Review","slug":"bispecific-antibodies-in-the-management-of-lymphoma-ash-2025-review","published_at":"2026-01-21T19:30:00+00:00","page_url":"https://stenobird.com/podcast/hematologic-oncology-update-916423/bispecific-antibodies-in-the-management-of-lymphoma-ash-2025-review","show_page_url":"https://stenobird.com/podcast/hematologic-oncology-update-916423","url":"https://hematologic-oncology.captivate.fm/episode/5606-ashbispecificslymphoma25","audio_url":"https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/2a2c2fe2-09a8-435e-b24d-9c07220c6366.mp3","summary":"Prof Michael Dickinson from Peter MacCallum Cancer Centre in Melbourne, Australia, and Dr Laurie H Sehn from the University of British Columbia in Vancouver, Canada, discuss clinical cases and recent findings from the 2025 ASH Annual Meeting relating to the use of bispecific antibodies in the management of lymphoma. CME information and select publications here .","meta_description":"Prof Michael Dickinson from Peter MacCallum Cancer Centre in Melbourne, Australia, and Dr Laurie H Sehn from the University of British Columbia in Vancouv…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3672,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/hematologic-oncology-update-916423/episodes/bispecific-antibodies-in-the-management-of-lymphoma-ash-2025-review/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/hematologic-oncology-update-916423/bispecific-antibodies-in-the-management-of-lymphoma-ash-2025-review.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}